ScholarIQanswers from OpenAlex & ORCID
Rosanne Lane
ResearcherPublications, citations & collaboration network
Rosanne Lane is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Rosanne Lane have?
ScholarIQindexed works
Rosanne Lane has 53 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Rosanne Lane have?
ScholarIQcitation count
Rosanne Lane has 6,657 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Rosanne Lane?
ScholarIQh-index
Rosanne Lane has an h-index of 28 in OpenAlex.
What is the i10-index of Rosanne Lane?
ScholarIQi10-index
Rosanne Lane has an i10-index of 35 in OpenAlex.
What is the OpenAlex record for Rosanne Lane?
ScholarIQopenalex
The OpenAlex for Rosanne Lane is on the source record.
What are the most-cited papers on Rosanne Lane?
ScholarIQmost cited works
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
Vanina Popova, Ella Daly, Madhukar H. Trivedi, Kimberly Cooper, Rosanne Lane, Pilar Lim, Christine Mazzucco, David Hough, Michael E. Thase, Richard C. Shelton, Patricio Molero, Eduard Vieta, Malek Bajbouj, Husseini K. Manji, Wayne C. Drevets, Jaskaran Singh
Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression
Ella Daly, Madhukar H. Trivedi, Adam Janik, Honglan Li, Yun Zhang, Xiang Li, Rosanne Lane, Pilar Lim, A. Duca, David Hough, Michael E. Thase, John Zajecka, Andrew Winokur, Ilona Divacka, Andrea Fagiolini, Wiesław Jerzy Cubała, István Bitter, Pierre Blier, Richard C. Shelton, Patricio Molero, Husseini K. Manji, Wayne C. Drevets, Jaskaran Singh
Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
Carla M. Canuso, Jaskaran Singh, Maggie Fedgchin, Larry Alphs, Rosanne Lane, Pilar Lim, Christine Pinter, David Hough, Gerard Sanacora, Husseini K. Manji, Wayne C. Drevets
Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
Maggie Fedgchin, Madhukar H. Trivedi, Ella Daly, Rama Melkote, Rosanne Lane, Pilar Lim, Dawn Vitagliano, Pierre Blier, Maurizio Fava, Michael R. Liebowitz, Arun Ravindran, Raphaël Gaillard, Hans van den Ameele, Sheldon Preskorn, Husseini K. Manji, David Hough, Wayne C. Drevets, Jaskaran Singh
Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression—TRANSFORM-3
Rachel Ochs-Ross, Ella Daly, Yun Zhang, Rosanne Lane, Pilar Lim, Randall L. Morrison, David Hough, Husseini K. Manji, Wayne C. Drevets, Gerard Sanacora, David C. Steffens, Caleb M. Adler, Rupert McShane, Raphaël Gaillard, Samuel T. Wilkinson, Jaskaran Singh